Pacific Biosciences of California, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $73.5M | $33.6M |
| FY2016 | $16.1M | $84.7M | $16.8M |
| FY2017 | $13.6M | $86.1M | $16.5M |
| FY2018 | $14.7M | $114.1M | $18.8M |
| FY2019 | $15.9M | $54.9M | $29.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $73.5M | $33.6M |
| FY2016 | $16.1M | $84.7M | $16.8M |
| FY2017 | $13.6M | $86.1M | $16.5M |
| FY2018 | $14.7M | $114.1M | $18.8M |
| FY2019 | $15.9M | $54.9M | $29.6M |